13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: Report from the childrens cancer study group-Reference-Cited by-同舟云学术

13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: Report from the childrens cancer study group

Published:1992 Issue:4 Volume:20 Page:307-311
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Finklestein Jerry Z.,Krailo Mark D.,Lenarsky Carl,Ladisch Stephen,Blair Geoffrey K.,Reynolds C. Patrick,Sitarz Anneliese L.,Hammond G. Denman

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology, and Child Health

Reference13 articles.

1. Retinoids and cancer

2. : Evidence for the ability of retinoic acid to regulate the phenotypic expression of human neuroblastoma. In (eds): “Modulation and Mediation of Cancer by Vitamins.” Basel: AG Karger, 1982.

3. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid;2024-05-14

2. Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects;Cancers;2024-01-26

3. Mitochondrial uncoupler and retinoic acid synergistically induce differentiation and inhibit proliferation in neuroblastoma;2024-01-25

4. Advances in the Management of Neuroblastoma;Critical Reviews in Eukaryotic Gene Expression;2024

5. Aryl hydrocarbon receptor is a tumor promoter in MYCN-amplified neuroblastoma cells through suppression of differentiation;iScience;2023-11